---
figid: PMC7284929__OMCL2020-8683404.007
figtitle: Ingenuity Pathway Analysis (IPA) and western blotting validation of common
  differentially expressed proteins
organisms:
- Armoracia rusticana
- Candida dubliniensis
- herbal medicine
- Grona styracifolia
- Mus musculus
- Rattus norvegicus
- Homo sapiens
pmcid: PMC7284929
filename: OMCL2020-8683404.007.jpg
figlink: pmc/articles/PMC7284929/figure/fig7/
number: F7
caption: 'Ingenuity Pathway Analysis (IPA) and western blotting validation of common
  differentially expressed proteins. (a) Top 15 canonical pathways according to IPA.
  The blue bars represent −log(P value), and the orange points denote the ratio of
  differentially expressed proteins. (b–d) Top 3 networks generated by IPA. Network
  1 is involved in metabolic disease, developmental disorder, and hereditary disorder
  (b); Network 2 is involved in energy production, lipid metabolism, and small molecule
  biochemistry (c); Network 3 is involved in lipid metabolism, small molecule biochemistry,
  and vitamin and mineral metabolism (d). (e) Validation of differentially expressed
  proteins PON1, GPD2, and APOA1 by western blotting. Data are shown as mean ± SEM,
  n = 5‐6. #P < 0.05 versus WT and ∗P < 0.05 versus ApoE−/−. WT: wild-type; BBR: berberine;
  PON1: paraoxonase 1; APOA1: apolipoprotein A I; GPD2: glycerol-3-phospate dehydrogenase
  2.'
papertitle: Improvement of Endothelial Dysfunction of Berberine in Atherosclerotic
  Mice and Mechanism Exploring through TMT-Based Proteomics.
reftext: Wangxiao Tan, et al. Oxid Med Cell Longev. 2020;2020:8683404.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6963261
figid_alias: PMC7284929__F7
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
redirect_from: /figures/PMC7284929__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7284929__OMCL2020-8683404.007.html
  '@type': Dataset
  description: 'Ingenuity Pathway Analysis (IPA) and western blotting validation of
    common differentially expressed proteins. (a) Top 15 canonical pathways according
    to IPA. The blue bars represent −log(P value), and the orange points denote the
    ratio of differentially expressed proteins. (b–d) Top 3 networks generated by
    IPA. Network 1 is involved in metabolic disease, developmental disorder, and hereditary
    disorder (b); Network 2 is involved in energy production, lipid metabolism, and
    small molecule biochemistry (c); Network 3 is involved in lipid metabolism, small
    molecule biochemistry, and vitamin and mineral metabolism (d). (e) Validation
    of differentially expressed proteins PON1, GPD2, and APOA1 by western blotting.
    Data are shown as mean ± SEM, n = 5‐6. #P < 0.05 versus WT and ∗P < 0.05 versus
    ApoE−/−. WT: wild-type; BBR: berberine; PON1: paraoxonase 1; APOA1: apolipoprotein
    A I; GPD2: glycerol-3-phospate dehydrogenase 2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HADHA
  - EVL
  - ENAH
  - ETFB
  - OPA1
  - MED12
  - PEX11A
  - ETFA
  - EHHADH
  - ACADM
  - SLC25A19
  - ACAD8
  - ACAD9
  - ACADL
  - ACADS
  - ACADVL
  - ACAD10
  - ACAD11
  - ACADSB
  - GCDH
  - IVD
  - EDNRB
  - DUOXA1
  - ABCB6
  - UQCRHL
  - CYTB
  - LETM1
  - NCOR1
  - SLC4A4
  - CD36
  - MTCO2P12
  - AKT1
  - AKT2
  - AKT3
  - TGFBI
  - UQCRC1
  - CA4
  - AFM
  - HSD11B1
  - ALB
  - APOA1
  - APOA2
  - APOE
  - CLU
  - NDUFA1
  - NDUFA13
  - ND3
  - MPC2
  - GPLD1
  - ACACB
  - NDUFC2
  - RMND1
  - KLK4
  - .na.character
  - PON1
  - VPS26C
  - HBA1
  - HBA2
  - HBB
  - HBD
  - HBE1
  - HBG1
  - HBG2
  - HBM
  - HBQ1
  - HBZ
  - TTR
  - FGL1
  - FBF1
  - PXDN
  - IDH3A
  - PGAM2
  - IDH3B
  - PRKAA2
  - PRKAA1
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - GOT1
  - GOT2
  - SCARB1
  - SAA1
  - SAA2
  - SAA4
  - CKM
  - FGA
  - FGB
  - FGG
  - GPT
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - DECR1
  - FABP4
  - GTF3A
  - TFAP2A
  - AK1
  - SERPINA1
  - GPD2
  - GAPDH
  - GAPDHP44
  - NR1H4
  - RXRA
  - RXRB
  - RXRG
  - ADRA1D
  - NR1H2
  - NR1H3
  - SARS2
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - Hadha
  - Evl
  - Enah
  - Etfb
  - Opa1
  - Med12
  - Pex11a
  - Etfa
  - Ehhadh
  - Acadm
  - Mup1
  - Mup4
  - Slc25a19
  - Mup12
  - Abcb6
  - Letm1
  - Ncor1
  - Ncor2
  - Slc4a4
  - Cd36
  - Scarb1
  - Akt1
  - Tgfbi
  - Cd320
  - Uqcrc1
  - Acadvl
  - Car4
  - Afm
  - Ndufa1
  - Ndufa13
  - Mpc2
  - Cbx4
  - Gpld1
  - Acacb
  - Ndufc2
  - Rmnd1
  - Klk1b9
  - Klk1b5
  - Klk1b8
  - Pon1
  - Vps26c
  - Ttr
  - Fgl1
  - Apoa1
  - Alb
  - Pxdn
  - Idh3a
  - Pgam2
  - Idh3b
  - Saa1
  - Saa2
  - Saa
  - Ckm
  - Gpt
  - Nfkb1
  - Decr1
  - Fabp4
  - Tfap2a
  - Ak1
  - Apoe
  - Gpd2
  - G6pd2
  - Gapdh
  - Nr1h4
  - Nr1h3
  - Nr1h2
  - Gnat2
  - Fndc3a
  - Prkaa2
  - Rela
  - Serpina1
  - Ccne1
  - 3-hydroxyacyl-CoA
  - enoyl
  - enoyl-CoA
  - CO2
  - NADH
  - O
  - NUDTZ
  - cholesterol
  - NADPH
  - Fatty acid B
  - Glutaryl
  - TCA
  - Tryptophan
  - Valine
  - GDP-glucose
  - Glucose
  - glucose
  - GDP-glucose biosynth  Glucose and glucose-1-phosp
  - Atherosclerosis signa
---
